Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Aug 29;5(5):683-685.
doi: 10.1016/j.jaccao.2023.07.004. eCollection 2023 Oct.

Metformin to Prevent Anthracycline Cardiotoxicity?: That Would Be Sweet!

Malak El-Rayes  1   2   3 , Michelle B Nadler  4   5 , Husam Abdel-Qadir  1   5   6   7   8
Affiliations
Editorial

Metformin to Prevent Anthracycline Cardiotoxicity?: That Would Be Sweet!

Malak El-Rayes et al. JACC CardioOncol. .
No abstract available

Keywords: anthracyclines; cardiotoxicity; diabetes; heart failure; metformin.

PubMed Disclaimer

Conflict of interest statement

Dr Nadler is supported by speaker honorarium and consulting fees from Novartis and Exact Sciences outside of the scope of this submitted work. Dr Abdel-Qadir is supported by a National New Investigator Award from the Heart and Stroke Foundation of Canada; and has received honoraria from Amgen, AstraZeneca, and Jazz Pharmaceuticals. Dr El-Rayes has reported that she has no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract
See this image and copyright information in PMC

Comment on

  • doi: 10.1016/j.jaccao.2023.05.013

References

    1. Thavendiranathan P., Abdel-Qadir H., Fischer H.D., et al. Breast cancer therapy-related cardiac dysfunction in adult women treated in routine clinical practice: a population-based cohort study. J Clin Oncol. 2016;34:2239–2246. - PubMed
    1. Abdel-Qadir H., Ong G., Fazelzad R., et al. Interventions for preventing cardiomyopathy due to anthracyclines: a Bayesian network meta-analysis. Ann Oncol. 2017;28:628–633. - PubMed
    1. Henriksen P.A., Rankin S., Lang N.N. Cardioprotection in patients at high risk of anthracycline-induced cardiotoxicity. J Am Coll Cardiol CardioOnc. 2023;5:292–297. - PMC - PubMed
    1. Wang L., Tan T.C., Halpern E.F., et al. Major cardiac events and the value of echocardiographic evaluation in patients receiving anthracycline-based chemotherapy. Am J Cardiol. 2015;116:442–446. - PubMed
    1. MacDonald M.R., Petrie M.C., Varyani F., et al. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur Heart J. 2008;29:1377–1385. - PubMed

Publication types

LinkOut - more resources